The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes
Biomolecules · 2026
DOI: 10.3390/biom16030416 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2026. Verfasst von Ushaswini Atluri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA. Hauptthemen laut MEDLINE: Keratinocytes, Cell Proliferation, Thiophenes, Nuclear Receptor Subfamily 1, Group D, Member 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institutes of Health, United States Department of Veterans Affairs.
Abstract (Originalsprache)
The small molecule SR8278 was initially identified as an antagonist of the REV-ERB (reverse c-ERBAa) nuclear receptor proteins, which play important roles in metabolism and circadian rhythms. Though SR8278 has been shown to have beneficial physiological effects in a variety of different preclinical disease contexts, its impact on gene expression and cell proliferation in keratinocytes has not previously been examined. We therefore carried out an RNA-seq analysis and found that genes involved in the G1/S transition of the cell cycle were significantly impacted by SR8278 treatment, and these effects were confirmed at both the RNA and protein level by RT-qPCR and Western blotting, respectively. Cell proliferation assays showed that SR8278 slowed cell growth but did not induce genotoxic stress or apoptosis. Finally, the use of CRISPR/Cas9 genome editing and siRNA-mediated disruption of REV-ERB gene expression showed that the loss of the REV-ERB proteins did not impact the effect of SR8278 on gene expression and cell proliferation. We conclude that the anti-proliferative effects of SR8278 are not mediated by the REV-ERB proteins, and, thus, care should be taken when interpreting studies involving this compound unless complementary genetic approaches are also shown, particularly in studies involving cell proliferation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, Wright State University Boonshoft School of Medicine, Dayton, OH 45435, USA.
- Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15232, USA.
- Dayton Veterans Affairs Medical Center, Dayton, OH 45428, USA.
ORCID-Profile: William Cvammen, Michael G Kemp
Förderung
- NIGMS NIH HHS
- National Institutes of Health
- United States Department of Veterans Affairs
- Ohio Cancer Research
Zitieren
APA
Atluri, U., Cvammen, W., & Kemp, M. G. (2026). The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes. Biomolecules. https://doi.org/10.3390/biom16030416
Vancouver
Atluri U, Cvammen W, Kemp MG. The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes. Biomolecules. 2026. doi:10.3390/biom16030416
BibTeX
@article{Atluri2026,
author = {Atluri, Ushaswini and Cvammen, William and Kemp, Michael G},
title = {The Small Molecule SR8278 Inhibits Cell Proliferation Independent of the REV-ERB Nuclear Receptor Proteins in Human Keratinocytes},
journal = {Biomolecules},
year = {2026},
doi = {10.3390/biom16030416}
}
EUVIMED